Abiopharma

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

New Form 20-F - MESOBLAST LTD Filed: 2025-08-29 AccNo: 0001345099-25-000067 Size: 44 MB

General Announcement: CHANGES IN DIRECTORS INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016

General Announcement: DEALINGS OUTSIDE CLOSED PERIOD

New Form SCHEDULE 13G - Jaguar Health, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-025884 Size: 6 KB

New Form 6-K - Haleon plc Filed: 2025-08-29 AccNo: 0001654954-25-010162 Size: 40 KB

New Form 6-K - Opthea Ltd Filed: 2025-08-29 AccNo: 0001193125-25-191693 Size: 521 KB

New Form EFFECT - CollPlant Biotechnologies Ltd Filed: 2025-08-28 AccNo: 9999999995-25-002768 Size: 2 KB

New Form EFFECT - PALISADE BIO, INC. Filed: 2025-08-28 AccNo: 9999999995-25-002773 Size: 1 KB

New Form 8-K - Arcturus Therapeutics Holdings Inc. Filed: 2025-08-29 AccNo: 0001193805-25-001247 Size: 236 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Smith+Nephew PLC Notification

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Financial Statements and Related Announcement: Full Yearly Results

Grey symbol attribute type Security_Name was changed. Previous value: CHEELCARE INC. New value: PHARMCHEM INC.

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016